{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T05:57:03Z","timestamp":1793771823202,"version":"4.6.1"},"reference-count":121,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PI23\/00798"],"award-info":[{"award-number":["PI23\/00798"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PI20\/00579"],"award-info":[{"award-number":["PI20\/00579"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PI 22\/00910"],"award-info":[{"award-number":["PI 22\/00910"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020098","name":"Innovative Health Initiative","doi-asserted-by":"publisher","award":["101132901"],"award-info":[{"award-number":["101132901"]}],"id":[{"id":"10.13039\/100020098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["847989"],"award-info":[{"award-number":["847989"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI23\/00798"],"award-info":[{"award-number":["PI23\/00798"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI20\/00579"],"award-info":[{"award-number":["PI20\/00579"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"HORIZON EUROPE Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jhep.2025.01.026","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T17:22:30Z","timestamp":1738257750000},"page":"258-270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Moving diagnosis of liver fibrosis into the community"],"prefix":"10.1016","volume":"83","author":[{"given":"Elisa","family":"Pose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9356-5830","authenticated-orcid":false,"given":"Salvatore","family":"Piano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6720-0291","authenticated-orcid":false,"given":"N\u00faria","family":"Fabrellas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5069-2461","authenticated-orcid":false,"given":"Emmanuel A.","family":"Tsochatzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4657-4504","authenticated-orcid":false,"given":"Pere","family":"Gin\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10258","key":"10.1016\/j.jhep.2025.01.026_bib1","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"issue":"10319","key":"10.1016\/j.jhep.2025.01.026_bib2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(21)01701-3","article-title":"The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality","volume":"399","author":"Karlsen","year":"2022","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jhep.2025.01.026_bib3","first-page":"245","article-title":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jhep.2025.01.026_bib4","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2025.01.026_bib5","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030","volume":"69","author":"Estes","year":"2018","journal-title":"J Hepatol"},{"issue":"10308","key":"10.1016\/j.jhep.2025.01.026_bib6","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Gin\u00e8s","year":"2021","journal-title":"Lancet"},{"issue":"10179","key":"10.1016\/j.jhep.2025.01.026_bib7","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(18)32111-1","article-title":"Clinical outcomes in patients with chronic hepatitis C after direct- acting antiviral treatment: a prospective cohort study","volume":"393","author":"Carrat","year":"2019","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.jhep.2025.01.026_bib8","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1111\/liv.13253","article-title":"Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients","volume":"36","author":"Su","year":"2016","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.jhep.2025.01.026_bib9","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jhep.2016.11.011","article-title":"Histological parameters and alcohol abstinence determine long-term prognosis in patients with alcoholic liver disease","volume":"66","author":"Lackner","year":"2017","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2025.01.026_bib10","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/HEP.0000000000000460","article-title":"Etiological cure prevents further decompensation and mortality in patients with cirrhosis with ascites as the single first decompensating event","volume":"78","author":"Tonon","year":"2023","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.jhep.2025.01.026_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0290352","article-title":"Late-stage presentation with decompensated cirrhosis is alarmingly common but successful etiologic therapy allows for favorable clinical outcomes","volume":"18","author":"Schwarz","year":"2023","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jhep.2025.01.026_bib12","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/hep.1840200611","article-title":"Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study","volume":"20","author":"Bellentani","year":"1994","journal-title":"Hepatology"},{"issue":"10159","key":"10.1016\/j.jhep.2025.01.026_bib13","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2025.01.026_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c1240","article-title":"Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies","volume":"340","author":"Hart","year":"2010","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.jhep.2025.01.026_bib15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hep.32163","article-title":"Population screening for liver fibrosis: toward early diagnosis and intervention for chronic liver diseases","volume":"75","author":"Gin\u00e8s","year":"2022","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jhep.2025.01.026_bib16","article-title":"Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practice","volume":"5","author":"Lazarus","year":"2022","journal-title":"JHEP Rep"},{"issue":"3","key":"10.1016\/j.jhep.2025.01.026_bib17","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jhep.2023.04.035","article-title":"Healthy Livers, Healthy Lives Collaborators. A global research priority agenda to advance public health responses to fatty liver disease","volume":"79","author":"Lazarus","year":"2023","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.jhep.2025.01.026_bib18","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1111\/liv.15941","article-title":"Use of non-invasive diagnostic tools for metabolic dysfunction-associated steatohepatitis: a qualitative exploration of challenges and barriers","volume":"44","author":"Tsochatzis","year":"2024","journal-title":"Liver Int"},{"issue":"9","key":"10.1016\/j.jhep.2025.01.026_bib19","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1080\/00365521.2021.1929450","article-title":"Diagnostic accuracy of routine liver function tests to identify patients with significant and advanced alcohol-related liver fibrosis","volume":"56","author":"Lindvig","year":"2021","journal-title":"Scand J Gastroenterol"},{"issue":"12","key":"10.1016\/j.jhep.2025.01.026_bib20","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1080\/00365521.2022.2094725","article-title":"Only one-third of referrals for fatty liver disease are on time: real-world study reveals opportunities to avoid unnecessary and delayed referrals","volume":"57","author":"Lindvig","year":"2022","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jhep.2025.01.026_bib21","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1053\/j.gastro.2003.10.065","article-title":"Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma","volume":"126","author":"El-Serag","year":"2004","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.jhep.2025.01.026_bib22","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S2213-8587(21)00288-6","article-title":"Trends in leading causes of hospitalisation of adults with diabetes in England from 2003 to 2018: an epidemiological analysis of linked primary care records","volume":"10","author":"Pearson-Stuttard","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"10.1016\/j.jhep.2025.01.026_bib23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jhep.2021.09.030","article-title":"Burden of liver disease progression in hospitalized patients with type 2 diabetes mellitus","volume":"76","author":"Mallet","year":"2022","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2025.01.026_bib24","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and MASH in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.jhep.2025.01.026_bib25","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.2337\/dc22-2048","article-title":"High prevalence of MASH and advanced fibrosis in type 2 diabetes: a prospective study of 330 outpatients undergoing liver biopsies for elevated ALT, using a low threshold","volume":"46","author":"Castera","year":"2023","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.jhep.2025.01.026_bib26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","article-title":"Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis","volume":"8","author":"Quek","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2025.01.026_bib27","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies","volume":"13","author":"Singh","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jhep.2025.01.026_bib28","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jhep.2021.02.034","article-title":"Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort","volume":"75","author":"Harrison","year":"2021","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.jhep.2025.01.026_bib29","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.31014","article-title":"Effect of metabolic traits on the risk of cirrhosis and hepatocellular cancer in nonalcoholic fatty liver disease","volume":"71","author":"Kanwal","year":"2020","journal-title":"Hepatology"},{"issue":"17","key":"10.1016\/j.jhep.2025.01.026_bib30","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective study of outcomes in adults with nonalcoholic fatty liver disease","volume":"385","author":"Sanyal","year":"2021","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.jhep.2025.01.026_bib31","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/s41575-023-00822-y","article-title":"The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease","volume":"20","author":"D\u00edaz","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2025.01.026_bib32","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/aje\/kws252","article-title":"Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study","volume":"177","author":"Loomba","year":"2013","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.jhep.2025.01.026_bib33","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1053\/j.gastro.2021.04.074","article-title":"Preparing for the MASH epidemic: a call to action","volume":"161","author":"Kanwal","year":"2021","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.jhep.2025.01.026_bib34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1053\/j.gastro.2018.03.038","article-title":"Improved diet quality associates with reduction in liver fat, particularly in individuals with high genetic risk scores for nonalcoholic fatty liver disease","volume":"155","author":"Ma","year":"2018","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.jhep.2025.01.026_bib35","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jhep.2009.05.033","article-title":"Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome","volume":"51","author":"Abid","year":"2009","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2025.01.026_bib36","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jhep.2016.08.023","article-title":"Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: a systematic review","volume":"66","author":"Hashida","year":"2017","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.jhep.2025.01.026_bib37","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"issue":"10200","key":"10.1016\/j.jhep.2025.01.026_bib38","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0140-6736(19)31775-1","article-title":"Alcohol use disorders","volume":"394","author":"Carvalho","year":"2019","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.jhep.2025.01.026_bib39","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.14309\/ajg.0000000000000340","article-title":"Alcohol consumption and risk of liver cirrhosis: a systematic review and meta-analysis","volume":"114","author":"Roerecke","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.jhep.2025.01.026_bib40","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1016\/j.cgh.2019.01.026","article-title":"Alcohol-related liver disease is rarely detected at early stages compared with liver diseases of other etiologies worldwide","volume":"17","author":"Shah","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.jhep.2025.01.026_bib41","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.10721","article-title":"Comparison of methods for alcohol and drug screening in primary care clinics","volume":"4","author":"McNeely","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.jhep.2025.01.026_bib42","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/jep.12854","article-title":"Improving screening and brief intervention activities in primary health care: secondary analysis of professional accuracy based on the AUDIT-C","volume":"24","author":"Palacio-Vieira","year":"2018","journal-title":"J Eval Clin Pract"},{"issue":"1","key":"10.1016\/j.jhep.2025.01.026_bib43","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/j.gastro.2015.09.040","article-title":"Transient and 2-dimensional shear-wave elastography provide comparable assessment of alcoholic liver fibrosis and cirrhosis","volume":"150","author":"Thiele","year":"2016","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.jhep.2025.01.026_bib44","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.cgh.2021.02.021","article-title":"Transient elastography accurately screens for compensated advanced chronic liver disease in patients with ongoing or recent alcohol withdrawal","volume":"20","author":"Legros","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.01.026_bib45","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.drugalcdep.2018.06.012","article-title":"Ultrasound findings of liver damage in a series of patients consecutively admitted for treatment of alcohol use disorder","volume":"190","author":"Fuster","year":"2018","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.jhep.2025.01.026_bib46","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jhep.2023.04.002","article-title":"Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease","volume":"79","author":"Kjaergaard","year":"2023","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.jhep.2025.01.026_bib47","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jhep.2025.01.026_bib48","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.eprac.2022.03.010","volume":"28","author":"Cusi","year":"2022","journal-title":"Endocr Pract"},{"issue":"3","key":"10.1016\/j.jhep.2025.01.026_bib49","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update","volume":"75","year":"2021","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2025.01.026_bib50","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2017-314924","article-title":"Guidelines on the management of abnormal liver blood tests","volume":"67","author":"Newsome","year":"2018","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.jhep.2025.01.026_bib51","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","article-title":"The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease","volume":"14","author":"Eslam","year":"2020","journal-title":"Hepatol Int"},{"issue":"6","key":"10.1016\/j.jhep.2025.01.026_bib52","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1002\/hep.30979","article-title":"Cost-effectiveness of noninvasive screening for alcohol-related liver fibrosis","volume":"71","author":"Asphaug","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.01.026_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102069","article-title":"Does knowledge of liver fibrosis affect high-risk drinking behaviour (KLIFAD): an open-label pragmatic feasibility randomised controlled trial","volume":"61","author":"Subhani","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"10","key":"10.1016\/j.jhep.2025.01.026_bib54","article-title":"Liver fibrosis screening increases alcohol abstinence","volume":"6","author":"Avitabile","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2025.01.026_bib55","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.puhe.2023.10.035","article-title":"The independent and joint risks of alcohol consumption, smoking, and excess weight on morbidity and mortality: a systematic review and meta-analysis exploring synergistic associations","volume":"226","author":"Burton","year":"2024","journal-title":"Public Health"},{"issue":"2","key":"10.1016\/j.jhep.2025.01.026_bib56","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jhep.2021.10.005","article-title":"A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers","volume":"76","author":"Whitfield","year":"2022","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2025.01.026_bib57","doi-asserted-by":"crossref","first-page":"8041","DOI":"10.1038\/s41467-023-43064-x","article-title":"Binge-pattern alcohol consumption and genetic risk as determinants of alcohol-related liver disease","volume":"14","author":"Ding","year":"2023","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.jhep.2025.01.026_bib58","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.34221","article-title":"Synergistic associations of PNPLA3 I148M variant, alcohol intake, and obesity with risk of cirrhosis, hepatocellular carcinoma, and mortality","volume":"5","author":"Kim","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.jhep.2025.01.026_bib59","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jhep.2024.06.036","article-title":"Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease","volume":"81","author":"Marti-Aguado","year":"2024","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.jhep.2025.01.026_bib60","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S2468-1253(23)00443-0","article-title":"Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: an analysis of data from a prospective cohort study","volume":"9","author":"Israelsen","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2025.01.026_bib61","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jhep.2022.01.016","article-title":"Cigarette smoking and liver diseases","volume":"77","author":"Marti-Aguado","year":"2022","journal-title":"J Hepatol"},{"issue":"10407","key":"10.1016\/j.jhep.2025.01.026_bib62","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(23)01320-X","article-title":"Hepatitis C","volume":"402","author":"Martinello","year":"2023","journal-title":"Lancet."},{"issue":"10381","key":"10.1016\/j.jhep.2025.01.026_bib63","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0140-6736(22)01468-4","article-title":"Hepatitis B","volume":"401","author":"Jeng","year":"2023","journal-title":"Lancet."},{"issue":"4","key":"10.1016\/j.jhep.2025.01.026_bib65","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S2468-1253(22)00386-7","article-title":"Global reporting of progress towards elimination of hepatitis B and hepatitis C","volume":"8","author":"Cui","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"43","key":"10.1016\/j.jhep.2025.01.026_bib66","first-page":"886","article-title":"Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965","volume":"61","author":"Smith","year":"2012","journal-title":"MMWR Recomm Rep"},{"issue":"8","key":"10.1016\/j.jhep.2025.01.026_bib67","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S2468-1253(22)00020-6","article-title":"Community pathways for the early detection and risk stratification of chronic liver disease: a narrative systematic review","volume":"7","author":"Abeysekera","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jhep.2025.01.026_bib68","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jhep.2019.03.033","article-title":"Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease","volume":"71","author":"Srivastava","year":"2019","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2025.01.026_bib69","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jhep.2019.05.033","article-title":"Intelligent liver function testing (iLFT): a trial of automated diagnosis and staging of liver disease in primary care","volume":"71","author":"Dillon","year":"2019","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.jhep.2025.01.026_bib70","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41575-024-00907-2","article-title":"Screening for liver fibrosis: lessons from colorectal and lung cancer screening","volume":"21","author":"Thiele","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jhep.2025.01.026_bib71","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.jhep.2022.04.009","article-title":"Structured early detection of asymptomatic liver cirrhosis: results of the population-based liver screening program SEAL","volume":"77","author":"Labenz","year":"2022","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jhep.2025.01.026_bib72","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1002\/hep.29631","article-title":"Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population","volume":"67","author":"\u00c5berg","year":"2018","journal-title":"Hepatology"},{"issue":"10406","key":"10.1016\/j.jhep.2025.01.026_bib73","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0140-6736(23)01174-1","article-title":"Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study","volume":"402","author":"Serra-Burriel","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jhep.2025.01.026_bib74","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1186\/s12889-022-13724-6","article-title":"LiverScreen Consortium investigators. LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries","volume":"22","author":"Graupera","year":"2022","journal-title":"BMC Public Health"},{"issue":"15","key":"10.1016\/j.jhep.2025.01.026_bib75","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jama.2024.1447","article-title":"Vibration-controlled transient elastography scores to predict liver-related events in steatotic liver disease","volume":"331","author":"Lin","year":"2024","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jhep.2025.01.026_bib76","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jhep.2024.02.019","article-title":"Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol-related liver disease","volume":"81","author":"Thorhauge","year":"2024","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jhep.2025.01.026_bib77","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-015659","article-title":"Economic evaluation of a community-based diagnostic pathway to stratify adults for non-alcoholic fatty liver disease: a Markov model informed by a feasibility study","volume":"7","author":"Tanajewski","year":"2017","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.jhep.2025.01.026_bib78","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jhep.2019.08.019","article-title":"Transient elastography for screening of liver fibrosis: cost-effectiveness analysis from six prospective cohorts in Europe and Asia","volume":"71","author":"Serra-Burriel","year":"2019","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.jhep.2025.01.026_bib79","doi-asserted-by":"crossref","first-page":"656","DOI":"10.12968\/bjon.2021.30.11.656","article-title":"From expert to advanced clinical practitioner and beyond","volume":"30","author":"Mortimore","year":"2021","journal-title":"Br J Nurs"},{"issue":"8","key":"10.1016\/j.jhep.2025.01.026_bib80","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1111\/j.1365-2648.2011.05624.x","article-title":"Nurse management of 'same day' consultation for patients with minor illnesses: results of an extended programme in primary care in Catalonia","volume":"67","author":"Fabrellas","year":"2011","journal-title":"J Adv Nurs"},{"issue":"6","key":"10.1016\/j.jhep.2025.01.026_bib81","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/jnu.12169","article-title":"Program of nurse management for unscheduled consultations of children with acute minor illnesses in primary care","volume":"47","author":"Fabrellas","year":"2015","journal-title":"J Nurs Scholarsh"},{"issue":"4","key":"10.1016\/j.jhep.2025.01.026_bib82","doi-asserted-by":"crossref","DOI":"10.12968\/pnur.2022.33.4.150","article-title":"The past, present and future of advanced nursing practice","volume":"33","author":"Swaby","year":"2022","journal-title":"Pract Nurs"},{"issue":"1","key":"10.1016\/j.jhep.2025.01.026_bib83","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jhep.2023.01.029","article-title":"Nursing care for patients with cirrhosis","volume":"79","author":"Fabrellas","year":"2023","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jhep.2025.01.026_bib84","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/NNR.0000000000000001","article-title":"Using transient elastography to detect chronic liver diseases in a primary care nurse consultancy","volume":"62","author":"Fabrellas","year":"2013","journal-title":"Nurs Res"},{"issue":"5","key":"10.1016\/j.jhep.2025.01.026_bib85","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1001\/jamainternmed.2018.0388","article-title":"Alcohol-related nurse care management in primary care: a randomized clinical trial","volume":"178","author":"Bradley","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"4","key":"10.1016\/j.jhep.2025.01.026_bib86","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/jamainternmed.2022.7083","article-title":"Integrating alcohol-related prevention and treatment into primary care: a cluster randomized implementation trial","volume":"183","author":"Lee","year":"2023","journal-title":"JAMA Intern Med"},{"issue":"12","key":"10.1016\/j.jhep.2025.01.026_bib87","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/j.1467-789X.2012.01029.x","article-title":"Nurse delivered lifestyle interventions in primary health care to treat chronic disease risk factors associated with obesity: a systematic review","volume":"13","author":"Sargent","year":"2012","journal-title":"Obes Rev"},{"issue":"1","key":"10.1016\/j.jhep.2025.01.026_bib88","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1080\/08897077.2022.2074602","article-title":"Barriers and facilitators to changing drinking and receiving alcohol-related care: interviews with Veterans Health Administration primary care patients who indicated interest but did not enroll in an alcohol care management intervention trial","volume":"43","author":"Frost","year":"2022","journal-title":"Subst Abus"},{"key":"10.1016\/j.jhep.2025.01.026_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2023.107498","article-title":"Primary prevention interventions for adults at-risk of obesity: an international scoping review","volume":"171","author":"Muntefering","year":"2023","journal-title":"Prev Med"},{"issue":"2","key":"10.1016\/j.jhep.2025.01.026_bib90","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2022.04.026","article-title":"The stigma of alcohol-related liver disease and its impact on healthcare","volume":"77","author":"Schomerus","year":"2022","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.jhep.2025.01.026_bib91","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jhep.2023.11.004","article-title":"Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease","volume":"80","author":"Younossi","year":"2024","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2025.01.026_bib92","doi-asserted-by":"crossref","DOI":"10.2196\/25927","article-title":"Usability and acceptability of a mobile app for the self-management of alcohol misuse among veterans (step away): pilot cohort study","volume":"9","author":"Malte","year":"2021","journal-title":"JMIR Mhealth Uhealth"},{"issue":"5","key":"10.1016\/j.jhep.2025.01.026_bib93","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1001\/jamapsychiatry.2013.4642","article-title":"A smartphone application to support recovery from alcoholism: a randomized clinical trial","volume":"71","author":"Gustafson","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.jhep.2025.01.026_bib94","doi-asserted-by":"crossref","DOI":"10.2196\/30416","article-title":"Long-term effectiveness of a smartphone app combined with a smart band on weight loss, physical activity, and caloric intake in a population with overweight and obesity (evident 3 study): randomized controlled trial","volume":"24","author":"Lugones-Sanchez","year":"2022","journal-title":"J Med Internet Res"},{"issue":"6","key":"10.1016\/j.jhep.2025.01.026_bib95","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.12417","article-title":"Effect of a smartphone app on weight change and metabolic outcomes in asian adults with type 2 diabetes: a randomized clinical trial","volume":"4","author":"Lim","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"9","key":"10.1016\/j.jhep.2025.01.026_bib96","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/ueg2.12323","article-title":"Comparison of various strategies to define the optimal target population for liver fibrosis screening: a population-based cohort study","volume":"10","author":"\u00c5berg","year":"2022","journal-title":"United Eur Gastroenterol J"},{"issue":"2","key":"10.1016\/j.jhep.2025.01.026_bib97","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jhep.2022.02.021","article-title":"Development and validation of a model to predict incident chronic liver disease in the general population: the CLivD score","volume":"77","author":"\u00c5berg","year":"2022","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.jhep.2025.01.026_bib98","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1016\/j.cgh.2021.12.034","article-title":"Low accuracy of FIB-4 and NAFLD fibrosis scores for screening for liver fibrosis in the population","volume":"20","author":"Graupera","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.jhep.2025.01.026_bib99","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/ajg.2016.453","article-title":"Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis","volume":"112","author":"McPherson","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"4 Pt 1","key":"10.1016\/j.jhep.2025.01.026_bib100","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1053\/jhep.2002.36128","article-title":"Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model","volume":"36","author":"Forns","year":"2002","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jhep.2025.01.026_bib101","doi-asserted-by":"crossref","first-page":"984","DOI":"10.14309\/ajg.0000000000001059","article-title":"A sequential algorithm combining ADAPT and liver stiffness can stage metabolic-associated fatty liver disease in hospital-based and primary care patients","volume":"116","author":"Eslam","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.jhep.2025.01.026_bib102","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1111\/liv.15595","article-title":"Validation of scores of PRO-C3 to predict liver-related events in alcohol-related liver disease","volume":"43","author":"J Johansen","year":"2023","journal-title":"Liver Int"},{"issue":"10","key":"10.1016\/j.jhep.2025.01.026_bib103","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1038\/s41591-023-02539-6","article-title":"Diagnostic performance of circulating biomarkers for non-alcoholic steatohepatitis","volume":"29","author":"Sanyal","year":"2023","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.jhep.2025.01.026_bib104","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jhep.2021.05.037","article-title":"Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease","volume":"75","author":"Rasmussen","year":"2021","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.jhep.2025.01.026_bib105","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/apt.13770","article-title":"Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference","volume":"44","author":"Munteanu","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.jhep.2025.01.026_bib106","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jhep.2019.04.020","article-title":"New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD","volume":"71","author":"Boursier","year":"2019","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.jhep.2025.01.026_bib107","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jhep.2023.04.031","article-title":"NIS2+\u2122, an optimisation of the blood-based biomarker NIS4\u00ae technology for the detection of at-risk MASH: a prospective derivation and validation study","volume":"79","author":"Harrison","year":"2023","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2025.01.026_bib108","article-title":"Determining a healthy reference range and factors potentially influencing PRO-C3 - a biomarker of liver fibrosis","volume":"3","author":"Erhardtsen","year":"2021","journal-title":"JHEP Rep"},{"issue":"2","key":"10.1016\/j.jhep.2025.01.026_bib109","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1148\/radiol.2020192437","article-title":"Update to the society of radiologists in ultrasound liver elastography consensus statement","volume":"296","author":"Barr","year":"2020","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.jhep.2025.01.026_bib110","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jhep.2023.04.025","article-title":"An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography","volume":"79","author":"Liang","year":"2023","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2025.01.026_bib111","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S2468-1253(19)30383-8","article-title":"FibroScan-AST (FAST) score for the non- invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study","volume":"5","author":"Newsome","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jhep.2025.01.026_bib112","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jhep.2022.10.034","article-title":"Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based Agile scores","volume":"78","author":"Sanyal","year":"2023","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2025.01.026_bib113","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jhep.2021.11.012","article-title":"MRI-based (MAST) score accurately identifies patients with MASH and significant fibrosis","volume":"76","author":"Noureddin","year":"2022","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.jhep.2025.01.026_bib114","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.3390\/diagnostics12071753","article-title":"Simultaneously screening for liver steatosis and fibrosis in Romanian type 2 diabetes mellitus patients using vibration-controlled transient elastography with controlled attenuation parameter","volume":"12","author":"Trifan","year":"2022","journal-title":"Diagnostics (Basel)"},{"issue":"2","key":"10.1016\/j.jhep.2025.01.026_bib115","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2337\/dc20-1997","article-title":"Advanced liver fibrosis is common in patients with type 2 diabetes followed in the outpatient setting: the need for systematic screening","volume":"44","author":"Lomonaco","year":"2021","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.jhep.2025.01.026_bib116","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3803\/EnM.2020.887","article-title":"Development of a non-invasive liver fibrosis score based on transient elastography for risk stratification in patients with type 2 diabetes","volume":"36","author":"Lee","year":"2021","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"2","key":"10.1016\/j.jhep.2025.01.026_bib117","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2337\/dc20-1778","article-title":"High prevalence of advanced liver fibrosis assessed by transient elastography among U.S. Adults with type 2 diabetes","volume":"44","author":"Ciardullo","year":"2021","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.jhep.2025.01.026_bib118","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1111\/jgh.14577","article-title":"Screening for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography","volume":"34","author":"Lai","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.jhep.2025.01.026_bib119","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1136\/gutjnl-2015-309265","article-title":"Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study","volume":"65","author":"Kwok","year":"2016","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.jhep.2025.01.026_bib120","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jhep.2022.11.010","article-title":"A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes","volume":"78","author":"Ajmera","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.01.026_bib121","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5582813","article-title":"Liver and nonliver-related outcomes at 2 Years are not influenced by the results of the FIB-4 test and liver elastography in a real-life cohort of patients with type 2 diabetes","volume":"2021","author":"Grgurevic","year":"2021","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2025.01.026_bib122","article-title":"Embedding assessment of liver fibrosis into routine diabetic review in primary care","volume":"3","author":"Mansour","year":"2021","journal-title":"JHEP Rep"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827825000637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827825000637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T01:03:58Z","timestamp":1766192638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827825000637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":121,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0168827825000637"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2025.01.026","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Moving diagnosis of liver fibrosis into the community","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2025.01.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}